Evidence map›Paper›PMID 34300096›Full record

ArticleInternational journal of environmental research and public health2021

Incidence and Outcomes of Pulmonary Embolism among Hospitalized COVID-19 Patients.

Omaima Ibrahim Badr, Hassan Alwafi, Wael Aly Elrefaey, Abdallah Y Naser, Mohammed Shabrawishi, Zahra Alsairafi, Fatemah M Alsaleh

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Review
  9. Article
  10. Epidemiological Features of COVID-19 in Makkah City: A Retrospective Data Analysis.Computational and mathematical methods in medicine · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 4 countries.

Omaima Ibrahim BadrDepartment of Chest Medicine, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt.
Hassan AlwafiFaculty of Medicine, Umm Al Qura University, Mecca 21514, Saudi Arabia.
Wael Aly ElrefaeyDepartment of Pulmonary Medicine, Al Noor Specialist Hospital, Mecca 20424, Saudi Arabia.
Abdallah Y NaserDepartment of Applied Pharmaceutical Sciences and Clinical Pharmacy, Faculty of Pharmacy, Isra University, Amman 11622, Jordan.ORCID 0000-0001-8440-7446
Mohammed ShabrawishiDepartment of Pulmonary Medicine, Al Noor Specialist Hospital, Mecca 20424, Saudi Arabia.ORCID 0000-0002-0050-2698
Zahra AlsairafiDepartment of Pharmacy Practice, Faculty of Pharmacy, Kuwait University, Kuwait City 12037, Kuwait.ORCID 0000-0003-1934-3751
Fatemah M AlsalehDepartment of Pharmacy Practice, Faculty of Pharmacy, Kuwait University, Kuwait City 12037, Kuwait.
Kuwait University · KWSaad Specialist Hospital · SAIsra University · JOMansoura University · EGUmm al-Qura University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesPatients with COVID-19 may be at high risk for thrombotic complications due to excess inflammatory response and stasis of blood flow. This study aims to assess the incidence of pulmonary embolism among hospitalized patients with COVID-19, risk factors, and the impact on survival.

methodsA retrospective case-control study was conducted at Al-Noor Specialist Hospital in Saudi Arabia between 15 March 2020 and 15 June 2020. Patients with confirmed COVID-19 diagnosis by a real-time polymerase chain reaction (PCR) and confirmed diagnosis of pulmonary embolism by Computed Tomography pulmonary angiogram (CTPA) formed the case group. Patients with confirmed COVID-19 diagnosis by a real-time polymerase chain reaction (PCR) and without confirmed diagnose of pulmonary embolism formed the control group. Logistic regression analysis was used to identify predictors of pulmonary embolism and survival.

resultsA total of 159 patients participated were included in the study, of which 51 were the cases (patients with pulmonary embolism) and 108 patients formed the control group (patients without pulmonary embolism). The incidence of PE among those hospitalized was around 32%. Smoking history, low level of oxygen saturation, and higher D-dimer values were important risk factors that were associated with a higher risk of developing PE (

conclusionsPulmonary embolism is common among hospitalized patients with COVID-19. Preventive measures should be considered for hospitalized patients with smoking history, low level of oxygen saturation, high D-dimer values, and high respiratory rate.

Indexed as

COVID-19Pulmonary EmbolismCase-Control StudiesComputed Tomography AngiographyCOVID-19 TestingHumansIncidenceRetrospective StudiesSARS-CoV-2Saudi ArabiaCOVID-19hospitalizedpulmonary embolismsurvival

Identifiers

PMID34300096
PMCPMC8307735
OpenAlexW3185851099

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.